BioDot
BioDot manufactures automated non-contact liquid dispensing systems at picoliter to microliter scales for diagnostics manufacturers, cytogenetics laboratories, and life sciences researchers globally, with 5,600+ platforms installed across 62 countries.
- Company typePrivate
- Founded1994
- HeadquartersIrvine, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioDot does
BioDot, founded in 1994 and headquartered in Irvine, California, manufactures automated non-contact liquid dispensing systems that operate at picoliter, nanoliter, and microliter scales for diagnostics, cytogenetics, and life sciences applications. Its proprietary technology stack spans BioJet, Rainmaker, AirJet, Ultra, PolyJet, PolyDrop, FrontLine, and uAirJet dispenser technologies, integrated into a portfolio of benchtop systems (NANOlab, Omnia, Sphera, MODULIS, AD series, XYZ series), large-format platforms (AD6020, RR120 web handling), and purpose-built cytogenetics automation (CellWriter S with FISHArray slides). The company's product surface supports assay miniaturization from early R&D through high-volume commercial manufacturing, with disposable tip technology enabling contamination-free operation and BDot Probe consumables (co-developed with Empire Genomics) extending into reagent workflows.
BioDot sells capital equipment, consumables, and service contracts through a direct enterprise field-sales motion, supported by feasibility studies, technical workshops (e.g., Lateral Flow Workshop), webinars, and an extensive resource library. The company serves more than 2,000 customers across 62 countries, with over 5,600 platforms installed globally contributing to billions of diagnostic tests and research outcomes annually. Primary customer segments include diagnostics manufacturers (lateral flow, point-of-care, biosensors), cytogenetics laboratories (FISH, karyotyping, FFPE), life science researchers (genomics, PCR, drug discovery, multiomics), and biosensor/biochip manufacturers. Pricing is not publicly disclosed and is handled through direct quotation based on system configuration.
In March 2026, BioDot was acquired by ATS Automation Tooling Systems Inc. (TSX: ATA) from Artemis Capital Partners and now operates as part of ATS Life Sciences Group, expanding its access to global industrial automation infrastructure. The company's February 2026 launch of NANOlab and MODULIS, combined with its SLAS 2026 New Product Award, signals active product-line expansion into genomics and scalable diagnostics manufacturing.
BioDot firmographics
Firmographics- Name
- BioDot
- Legal name
- BioDot Inc.
- Website
- https://biodot.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- BioDot manufactures automated non-contact liquid dispensing systems at picoliter to microliter scales for diagnostics manufacturers, cytogenetics laboratories, and life sciences researchers globally, with 5,600+ platforms installed across 62 countries.
- Ownership category
- akta.pro rank
BioDot industry classification
Industry- Product category
- Precision Liquid Handling and Dispensing Systems
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH), Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware) (IMAAAAAG)
Keywords
Where BioDot is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioDot business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Precision Liquid Handling Systems: BioDot generates revenue from selling automated dispensing platforms including benchtop dispensers (AD1520, AD3220, NANOlab, Omnia, Sphera), large format systems (AD6020, RR120), and specialized systems (CellWriter S, XYZ series). These are capital equipment purchases for R&D and manufacturing.
- Consumables and Consumable Kits: Revenue from disposable tips, FISHArray slides, BDot Probe tubes (in partnership with Empire Genomics), and other consumables required for ongoing operations of BioDot systems.
- Service and Support: Technical support, application support, IQ/OQ validation services, preventative maintenance plans, remote support, and service level agreements for installed base.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
BioDot product offering
Product offeringCore offering
BioDot manufactures and sells automated non-contact dispensing platforms for ultra-low-volume (picoliter to microliter) liquid handling, including benchtop dispensers, large-format manufacturing systems, cytogenetics slide preparation instruments, and supporting consumables. The platforms serve diagnostics manufacturers producing lateral flow and point-of-care tests, cytogenetics laboratories performing FISH and karyotyping, and life sciences researchers conducting genomics, proteomics, and drug discovery workflows.
Product overview
BioDot offers a comprehensive portfolio of precision liquid handling and dispensing systems spanning benchtop dispensers to large-format manufacturing platforms. The core product line includes: NANOlab (nanoliter-scale liquid handler for genomics workflows), Omnia/Omnia Discovery (picoliter to microliter precision dispensers), Sphera/Sphera Discovery (Lyobead dispensing systems), MODULIS (scalable diagnostics manufacturing platform), and CellWriter S (automated cytogenetics slide system). Supporting systems include the XYZ series (benchtop dispensers for lateral flow/immunoblot), AD series (aspirate/dispense systems), and RR120 (web handling for high-volume manufacturing). Technologies include BioJet, Rainmaker, AirJet, FrontLine, PolyJet, Ultra, and uAirJet dispensing technologies. The company serves diagnostics, cytogenetics, life sciences, and medical device markets globally.
Differentiator
Problem solved
Functional benefit
Brands
- NANOlab™: High-precision nanoliter liquid handling system engineered for advanced genomics workflows featuring disposable pipette tips, contamination-free operation, and walk-away automation.
- Sphera™
- Sphera™ Discovery
- Omnia™ Discovery
- MODULIS™
- CellWriter™ S
- FISHArray™
- BioJet™
- Rainmaker™
- Lyobead™
Products and services
- NANOlab High-precision nanoliter liquid handler designed for real lab workflows in genomics, PCR, drug discovery, and multiomics applications. Features disposable pipette tips, walk-away automation, and modular scalable architecture for life sciences laboratories.
- Omnia Discovery Precision picoliter to nanoliter dispensing platform for genomics, proteomics, and drug discovery applications, leveraging Rainmaker and BioJet technologies for unmatched speed and precision.
- Omnia Aspirate Dispensing System Precision picoliter, nanoliter, and microliter drop dispenser using Rainmaker and BioJet technologies for applications where drop size precision is critical.
- Sphera Discovery Compact Lyobead Dispensing System bringing cutting-edge lyophilized bead technology to laboratory settings in an efficient benchtop platform.
- Sphera Lyobead dispensing system for precise formation and handling of lyophilized beads for various diagnostic applications.
- MODULIS Scalable liquid dispensing system for diagnostics manufacturing, designed for flexible workflow configuration and high-throughput processing.
- CellWriter S Automated slide production system for Karyotyping, FISH, and FFPE applications. Uses BioJet technology with FISHArray slides to simplify assays, eliminate rubber cement, and enable fully automated FISH workflows with LIMS integration.
- AD3220 Aspirate Dispense System Aspirate and dispense platform for R&D and pilot production with high-speed dispensing to slides, microtiter plates, membranes, or custom surfaces.
- AD6020 Aspirate Dispense System High-throughput multi-channel automated liquid handling system with customizable nest for diverse applications including biosensor, microarray, and low-volume PCR manufacturing.
- RR120 Web Handling System High-volume modular system for printing, coating, inspecting, and drying rolls, supporting lateral flow and dry chemistry coating at scale.
- XYZ3210 Dispense System Dispense system for rapid test development and manufacturing, with a larger deck than XYZ3060 supporting multiple dispensing technologies.
- XYZ3210-C Dispense System Dispense system designed for immunoblot manufacturing with larger deck area than the XYZ3060, featuring multiple dispensing channels and technologies.
- FISHArray Slides Low-volume multi-welled consumable slides for FISH assays that enable true multiplexing with up to 8 unique assays performed on a single slide.
- BDot Probe Ready-to-use, pre-filled PIM tubes of hematologic markers developed in collaboration with Empire Genomics and designed exclusively for the CellWriter S platform.
- BioDot Service and Support Technical support, application support, IQ/OQ validation services, preventative maintenance plans, remote support, and service level agreements for the installed base of precision liquid handling systems.
Quantifiable outcome
- Drops volumes as low as 25 picoliters
- +2 more outcomes
Companies that use BioDot
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
BioDot technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature8 records
BioDot partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Empire GenomicscoreBioDot collaborated with Empire Genomics to introduce the BDot Probe line, designed exclusively for the CellWriter S platform. These ready-to-use, pre-filled PIM tubes cover a broad range of hematologic markers. The partnership enables a fully automated FISH workflow that saves time and resources, reduces human error, and delivers reliable signals.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
BioDot competitors and assessment
Company assessmentDirect peers
- Hamilton Company: Hamilton is a leading manufacturer of precision liquid handling workstations and automated pipetting systems used in diagnostics, genomics, and life science research. Directly competes with BioDot in lab-scale and production-scale low-volume dispensing for diagnostic and biotech workflows.
- Tecan: Tecan is a major provider of laboratory automation and liquid handling platforms, including precision dispensing for diagnostics manufacturing, genomics, and clinical labs. Competes with BioDot in both OEM-style dispensing modules and full integrated workstations for IVD manufacturers.
- Gilson: Gilson specializes in precision liquid handling instruments including pipetting and dispensing systems for life sciences and analytical labs. Overlaps with BioDot in low-volume precision dispensing, particularly in research and quality control applications.
- TTP Labtech: TTP Labtech designs low-volume liquid handling and nanodispensers for genomics, drug discovery, and biochemical research. Directly comparable to BioDot's NANOlab and Omnia platforms in genomics and miniaturized assay workflows.
Broad incumbents
- Beckman Coulter Life Sciences: Beckman Coulter offers automated liquid handlers, bioreactors, and lab automation under the broader Danaher umbrella, serving similar diagnostics and life science customers. Overlaps with BioDot in high-throughput dispensing for genomics and diagnostics workflows but within a much wider instrumentation portfolio.
- PerkinElmer (Revvity): Revvity (formerly PerkinElmer) provides a broad range of life science instrumentation including liquid handling, detection, and reagents for diagnostics and research. Comparable to BioDot in diagnostics OEM and genomics workflows, though BioDot is more focused on the ultra-low-volume dispensing niche.
- Mettler Toledo: Mettler Toledo provides precision laboratory instruments including automated liquid handling and dosing systems used in pharma, biotech, and diagnostics manufacturing. Comparable to BioDot in production-scale reagent dispensing for IVD manufacturers, though its portfolio is much broader.
Emerging players
- Dispendix (a Bionova Scientific brand): Dispendix focuses on non-contact low-volume dispensing for genomics and high-throughput screening applications, with proprietary picodroplet technology. Closely comparable to BioDot's BioJet and Rainmaker platforms in ultra-low-volume dispensing for life sciences research.
- Cytena (a CELLINK brand): Cytena specializes in single-cell dispensing and cell printing technologies for cell line development and bioprinting applications. Comparable to BioDot's cell dispensing/cell printing and CellWriter capabilities in life sciences workflows.
Others
- ATS Automation Tooling Systems (parent): ATS Automation is BioDot's corporate parent since March 2026 and operates adjacent automation capabilities in life sciences and industrial automation. As the acquirer, ATS provides manufacturing automation scale relevant to BioDot's diagnostic manufacturing customers but is not a direct product competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
BioDot social profiles
Digital presenceBioDot financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioDot leadership team
Management profileNumber of profiles
Profiles3 records
BioDot funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioDot M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioDot
What does BioDot do?
BioDot manufactures and sells automated non-contact dispensing platforms for ultra-low-volume (picoliter to microliter) liquid handling, including benchtop dispensers, large-format manufacturing systems, cytogenetics slide preparation instruments, and supporting consumables. The platforms serve diagnostics manufacturers producing lateral flow and point-of-care tests, cytogenetics laboratories performing FISH and karyotyping, and life sciences researchers conducting genomics, proteomics, and drug discovery workflows.
Is BioDot a public or private company?
BioDot is a private company. It is classified as corporate owned and is currently acquired.
When was BioDot founded?
BioDot was founded in 1994. It employs 51 to 100 people.
Where is BioDot based?
BioDot is headquartered in Irvine, United States, in the North America region.
How does BioDot make money?
Three revenue lines are on record. Precision Liquid Handling Systems are the primary driver. The others are consumables and Consumable Kits and service and Support.
Who are BioDot's main competitors?
Direct peers on record are Hamilton Company, Tecan, Gilson and TTP Labtech. Broad incumbents are Beckman Coulter Life Sciences, PerkinElmer (Revvity) and Mettler Toledo. Emerging players are Dispendix (a Bionova Scientific brand) and Cytena (a CELLINK brand). ATS Automation Tooling Systems (parent) is listed as an others.
Does BioDot have an API?
No public API is recorded for BioDot.
What industry is BioDot in?
BioDot's product category is Precision Liquid Handling and Dispensing Systems. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3826.